Skip to main content
ENGN logo

ENGN · enGene Therapeutics Inc.

$1.80 -0.02 (-0.83%)
Market Cap
$121.92M
Shares
66.99M

Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.

Fails to Deliver History

Settlement Date Quantity Price Value
2026-06-25 20,000 $1.75 $35,000
2026-06-17 3,603 $1.75 $6,305
2026-06-16 47,807 $1.77 $84,618
2026-06-11 126,304 $1.60 $202,086
2026-06-10 58,371 $1.67 $97,480
2026-06-05 70 $1.72 $120
2026-05-29 983 $1.78 $1,750
2026-05-12 305,146 $1.49 $454,668
2026-05-11 282,835 $1.50 $424,253
2026-05-06 11,359 $7.89 $89,623
Showing 1–10 of 10 settlements
Key facts CIK 1980845 CUSIP 29286X101 13F (30d) 5 filings 5 filers Visit website